Clonal expansion of colistin resistant Acinetobacter baumannii isolates in Cape Town, South Africa.
Description of colistin resistant Acinetobacter baumannii isolates in Cape Town, South Africa. A. baumannii isolates identified on Vitek® 2 AES™ were collected from Tygerberg Hospital referral laboratory between 2016 and 2017. Colistin resistance was confirmed using broth microdilution and SensiTest™. mcr-1-5 were detected using PCR and strain typing was performed by rep-PCR. Whole genome sequencing (WGS) was performed on a subset of isolates to identify chromosomal colistin resistance mechanisms and strain diversity using multilocus sequence typing (MLST) and pairwise single nucleotide polymorphism analyses. Twenty-six colistin resistant and 6 colistin susceptible A. baumannii were collected separately based on Vitek susceptibility; 20/26 (77%) were confirmed colistin resistant by BMD. Four colistin resistant isolates were isolated in 2016, and 16 in 2017, from 5 healthcare facilities. Thirteen colistin resistant isolates and 8 colistin susceptible isolates were identical by rep-PCR and MLST (ST1), all from patients admitted to a tertiary hospital during 2017. The remaining colistin resistant isolates were unrelated. An increase in colistin resistant A. baumannii isolates from a tertiary hospital in 2017 appears to be clonal expansion of an emerging colistin resistant strain. This strain was not detected in 2016 or from other hospitals. Identical colistin susceptible isolates were also isolated suggesting relatively recent acquisition of colistin resistance.